Dr. Robinett graduated with honors from Virginia Tech with majors in Chemistry, Biochemistry and Biology. She went on to complete her M.D. at the University of Maryland School of Medicine. At the University of North Carolina, Chapel Hill she completed an internship and residency in Internal Medicine. After that, she returned to the University of Maryland School of Medicine for fellowship training in Pulmonary and Critical Care Medicine. Once her fellowship was completed she stayed on as faculty with a specific clinical and research focus on severe asthma.
Dr. Robinett began research in obstructive lung disease and asthma prior to entering medical school. During her fellowship she resumed her research career with a focus on basic and translational research targeting treatments for severe asthmatics. Specifically, she has been involved with the discovery of bitter taste receptors on human airway smooth muscle and the role they could play in the treatment of asthma and chronic obstructive lung disease (COPD). Additionally she is starting a translational research project to help understand the mechanism by which bronchial thermoplasty improves asthma symptoms and decreases severe exacerbations.
Dr. Robinett has a clinic specifically focused on severe asthmatics. Part of her expertise involves the treatment of severe asthmatics with omalizumab (Xolair) and bronchial thermoplasty when more conventional treatments have failed.